340B Drug Pricing Program

Unpacking the 340B Drug Pricing Program, Its Impact on the Pharmaceutical Industry

November 9, 2022 - The 340B Drug Pricing Program has evolved significantly since its establishment in 1992. According to an article published by the Commonwealth Fund, the 340B Program is a federal drug pricing program that allows certain hospitals, clinics, and healthcare facilities to buy drugs at a discounted rate. The discount ranges from 25 to 50%. The program predominantly covers facilities that...

Read More


More Articles

Epic’s Broad Pharmacy Development Increases But Gaps Remain

by Samantha McGrail

Recently, Epic has prioritized broad pharmacy development. A recent KLAS report, Epic Pharmacy, looked to validate if this is the right move for Epic’s customers and where gaps may...

GAO Flags Lack of 340B Drug Discount Program Oversight

by Ana Mulero

Weakness in the oversight of the 340B Drug Discount Program allowed some hospitals to get discounted drugs they were ineligible for, a Government Accountability Office analysis found.  Hospitals,...

Recent Articles